Target intelligence / Profile preview

Bacterial glycolytic enzymes

Molecular classification
Enzyme
01

Overview

Bacterial glycolytic enzymes in dental biofilm are a collective group of metabolic proteins, including enolase, lactate dehydrogenase, and pyruvate kinase, that facilitate the fermentation of dietary sugars into organic acids (Takahashi & Nyvad, 2011, Journal of Dental Research). This metabolic pathway is a primary virulence factor for cariogenic bacteria such as Streptococcus mutans, as the resulting lactic acid lowers the local pH and triggers the demineralization of tooth enamel (Selwitz et al., 2007, The Lancet). These enzymes are essential for the energy production and survival of acidogenic microbes within the complex architecture of the oral biofilm. Therapeutic strategies often target these enzymes to curtail acid production and disrupt bacterial metabolism; for instance, fluoride ions are well-known inhibitors of bacterial enolase, effectively reducing the glycolytic flux (Marquis et al., 2003, Canadian Journal of Microbiology). Additionally, sugar alcohols like xylitol can interfere with the transport and phosphorylation of sugars, effectively stalling the glycolytic pathway (Trahan, 1995, International Dental Journal). By modulating the activity of these enzymes, clinicians can control the pathogenicity of the dental biofilm and prevent the progression of tooth decay.

Other names
Glycolytic pathway enzymesOral biofilm metabolic enzymesCariogenic bacterial enzymesBacterial acidogenic enzymes
02

Mechanism of action

Inhibition of specific enzymes such as enolase and lactate dehydrogenase, and disruption of the phosphoenolpyruvate-mediated phosphotransferase system (PEP-PTS), leading to reduced lactic acid production and bacterial growth inhibition.

03

Biological functions

Carbohydrate metabolismAcidogenesis (acid production)Energy production (ATP synthesis)Anaerobic fermentation
04

Disease associations

Dental caries (tooth decay)InfectionPeriodontitisOral dysbiosis
05

Safety considerations

Dental fluorosis (with excessive fluoride intake)Oral microbiome dysbiosisTooth staining (associated with chlorhexidine)Gastrointestinal distress (associated with high xylitol consumption)Potential for antimicrobial resistance
06

Interacting drugs

Fluoride

5 more in the full profile.

07

Biomarkers

Biofilm pH (Stephan curve)Lactic acid concentration in plaqueStreptococcus mutans colony forming units (CFU)Enolase activity levelsLactate dehydrogenase (LDH) activity

Beyond the preview

Go deeper on Bacterial glycolytic enzymes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial glycolytic enzymes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call